+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Prostacyclin"

Calcium Channel Blocker Market Report 2025 - Product Thumbnail Image

Calcium Channel Blocker Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Pulmonary Arterial Hypertension Market Report 2025 - Product Thumbnail Image

Pulmonary Arterial Hypertension Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Pulmonary Arterial Hypertension - Epidemiology Forecast - 2034 - Product Thumbnail Image

Pulmonary Arterial Hypertension - Epidemiology Forecast - 2034

  • Report
  • December 2024
  • 125 Pages
  • Global
From
Pulmonary Arterial Hypertension (PAH) Drugs Market 2024-2028 - Product Thumbnail Image

Pulmonary Arterial Hypertension (PAH) Drugs Market 2024-2028

  • Report
  • July 2024
  • 180 Pages
  • Global
From
Antihypertensives: Global Markets to 2023 - Product Thumbnail Image

Antihypertensives: Global Markets to 2023

  • Report
  • January 2019
  • 144 Pages
  • Global
From
From
Ischemia Reperfusion Injury - Pipeline Insight, 2024 - Product Thumbnail Image

Ischemia Reperfusion Injury - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 50 Pages
  • Global
From
Treprostinil Palmitil Emerging Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

Treprostinil Palmitil Emerging Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • December 2022
  • 30 Pages
  • Global
From
Orenitram Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

Orenitram Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • December 2022
  • 30 Pages
  • Global
From
Loading Indicator

Prostacyclin is a type of cardiovascular drug used to treat a variety of conditions, including pulmonary arterial hypertension, deep vein thrombosis, and coronary artery disease. It works by inhibiting platelet aggregation and reducing the risk of blood clots. Prostacyclin is typically administered intravenously or subcutaneously, and is available in both generic and branded forms. It is also used in combination with other drugs to treat certain conditions. The prostacyclin market is highly competitive, with a number of companies offering products for the treatment of cardiovascular diseases. These companies include Actelion Pharmaceuticals, Bayer AG, GlaxoSmithKline, Merck & Co., Novartis AG, Pfizer Inc., and Sanofi. Show Less Read more